Kuzma v. N. Ariz. Healthcare Corp.
The defendants in this qui tam case asked for summary judgment against the plaintiff Relator, who had alleged violations of the False Claims Act as it related to the sale of Surgery and Rehabilitation Centers by the defendants. Relator brought suit against the defendants, alleging they violated the FCA by overpaying the physician-owners of the Summit Center to reward them for past business and to induce future business in violation of the federal Anti-Kickback Statute. The defendants advanced three arguments in favor of summary judgment: (1) the acquisition price paid for the Summit Center was fair market value; (2) Relator had no evidence that the defendants acted with the requisite scienter; and (3) Relator cannot show a causal link between the alleged kickback and the submission of false claims.
U.S. District Court Partially Denies Motion for Summary Judgment Regarding Qui Tam Case on Excess Purchase Price Under the False Claims Act
The defendants in this qui tam case asked for summary judgment against the plaintiff Relator, who had alleged violations of the False Claims Act as it related to the sale of Surgery and Rehabilitation Centers by the defendants. Relator brought suit against the defendants, alleging they violated the FCA by overpaying the physician-owners of the Summit Center to reward them for past business and to induce future business in violation of the federal Anti-Kickback Statute. The defendants advanced three arguments in favor of summary judgment: (1) the acquisition price paid for the Summit Center was fair market value; (2) Relator had no evidence that the defendants acted with the requisite scienter; and (3) Relator cannot show a causal link between the alleged kickback and the submission of false claims.
A Lesson in Healthcare Supply and Demand—and Market Power, Part 2
This is Part 2 of a two-part article that follows up on the author’s landmark research on the fair market value of physician compensation. The issue of insurance market structure and the related impact on the negotiating of provider contracts was addressed in Part 1 of this article. Physician distribution and the impact of local payment rates that determine compensation is addressed in Part 2.
A Lesson in Healthcare Supply and Demand—and Market Power, Part 1
This is a follow-up to the author’s landmark research on the fair market value of physician compensation. The issue of insurance market structure and the related impact on the negotiating of provider contracts is addressed in Part 1 of this article. Physician distribution and the impact of local payment rates that determine compensation is addressed in Part 2.
Healthcare Valuations: A Check Up
Since March 2020, the United States healthcare industry has faced great adversity. COVID-19 has impacted the way hospitals pay their physicians forever. Join Kathryn Taylor and Justin Conant for your annual Healthcare Valuation Checkup. Get up to speed on the current environment surrounding physician compensation and review the top 10 issues potentially impacting physician compensation in 2022. Learn critical topics such as the group practice exception, advanced practice provider supervision and personally performed work, value-based ...
Imaging centers: If you’ve seen one, you haven’t seen them all
If you value the local hardware store, the next one you value is likely to look pretty much the same.
Physician Distribution, Mobility, Fair Market Value, and Compensation Surveys: An Update
This article updates the author’s peer-reviewed research on the geographic distribution of physicians in the United States, including some key commentary from CMS about the use of surveys for Stark fair market value.
‘Survey Says’ for FMV of Physician Compensation Is on Its Last Legs
The use of compensation surveys to determine the fair market value of physician compensation is seriously flawed, a position well-known expert Mark Dietrich has long maintained. Plus, recent government regulations confirm his position. He offers an alternate methodology.
Economy, Cannabis, Physician Pay, SPACs, and Expert Testimony Among the Hot Topics at the NJCPA BV Conference
Key takeaways from the 2021 New Jersey CPA Society’s Business Valuation and Litigation Services Conference are included.
Dietrich updates landmark research on physician compensation
The December issue of Business Valuation Update includes an article by Mark Dietrich that updates his important research on the geographic distribution of physicians in the United States.
BV News and Trends October 2021
A monthly roundup of key developments of interest to business valuation experts.
Two state CPA societies host BV events this month
Some state CPA societies organize business valuation conferences, and two of them are coming up later this month.
New rules for FMV in healthcare should dull DOJ’s sword
The Department of Justice has taken an aggressive stance in fraud and abuse cases involving the measurement of fair market value of physician compensation.
Check out the NJCPA’s annual BV conference September 21
The Biden tax proposals, physician compensation, cannabis, and SPACs are some of the cutting-edge topics you’ll hear about at this year’s Business Valuation and Litigation Services Conference, hosted by the New Jersey Society of CPAs.
New Ballgame for FMV in Healthcare Under Final CMS Rules
The valuation profession is now in the driver’s seat with respect to the definition of fair market value for healthcare regulatory purposes. The game changer is in the final rules from the Centers for Medicare & Medicaid Services (CMS) related to the Stark Law. There is also a call for papers.
Physician Compensation and COVID-19: Then and Now and Now What?
PYA’s Kathryn Taylor, CPA/ABV, ASA, MBA (consulting senior manager), and Justin Conant (consulting senior staff) will be presenting Physician Compensation and COVID-19: Then and Now and Now What. In this 100-minute session, Kathryn and Justin will review what physician compensation was like before COVID-19 and how it changed during the pandemic. Next, we will look into the future and explain where physician compensation and physician arrangements are headed. Kathryn and Justin will go through topics ...
Call for papers: New Stark regs and healthcare valuation
We here at BVR are putting together a special report on the revised definition of fair market value (FMV) for the Stark regulations.
BV News and Trends May 2021
A monthly roundup of key developments of interest to business valuation experts.
BVU News and Trends April 2021
A monthly roundup of key developments of interest to business valuation experts.
Valuing Telehealth Services
Join Todd Zigrang and Jessica L. Bailey-Wheaton for a discussion of the valuation of telehealth services in the healthcare industry. Learn the current telehealth trends and the role of telehealth in the healthcare industry. Gain an understanding of the types of telehealth services typically provided, such as clinical services, management services, and the provision of technology, and how these services may vary by healthcare industry subsector. Get expert guidance on typical valuation approaches as they ...
Tomorrow is the deadline for proposals for healthcare papers
April 15 is the deadline for proposals for papers on issues of fair market value, general market value, and commercial reasonableness under the new Stark regulations.
Deadline looms for papers on new Stark regs and healthcare valuation
April 15 is the deadline for proposals for papers on issues of fair market value, general market value, and commercial reasonableness under the new Stark regulations.
April 15 deadline for call for papers on new Stark regs and healthcare valuation
BVR is seeking proposals for papers on issues of fair market value, general market value, and commercial reasonableness under the new Stark regulations.
New association formed for healthcare compensation pros
The American Association of Provider Compensation Professionals (AAPCP) is a new nonprofit group whose members advise and lead healthcare organizations on provider compensation, contracting, planning, recruitment, retention, strategy, and, yes, valuation.
Call for papers: New Stark regs and healthcare valuation
Recent regulatory changes will have a significant impact on valuations in the healthcare sector, and BVR is developing content designed to help practitioners navigate the new rules.
- 1
- 2 (current)
- 3
- 4
- 5